SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

5.650 +0.470 (+9.07%)

Streaming Delayed Price Updated: 3:23 PM EST, Mar 5, 2026 Add to My Watchlist

Price and Volume

Volume	59,582
Open	5.040
Bid (Size)	5.490 (900)
Ask (Size)	5.650 (100)
Prev. Close	5.180
Today's Range	4.630 - 5.690
52wk Range	0.4621 - 10.81
Shares Outstanding	145,148,593
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

SciSparc Announces 1-for-9 Reverse Share Split

March 02, 2026

From SciSparc Ltd

Via GlobeNewswire

SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA

February 02, 2026

From SciSparc Ltd

Via GlobeNewswire

Performance

YTD	+303.6%	+303.6%
1 Month	+633.8%	+633.8%
3 Month	+230.4%	+230.4%
6 Month	+155.7%	+155.7%
1 Year	-17.2%	-17.2%

More News

SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization

January 26, 2026

From SciSparc Ltd

Via GlobeNewswire

Which stocks are moving after the closing bell on Wednesday? ↗

January 21, 2026

Via Chartmill

These stocks are gapping in today's session ↗

January 13, 2026

Via Chartmill

These stocks that are showing activity before the opening bell on Tuesday. ↗

January 13, 2026

Via Chartmill

SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity

January 13, 2026

From SciSparc Ltd

Via GlobeNewswire

SciSparc Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

January 12, 2026

From SciSparc Ltd

Via GlobeNewswire

SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects

December 30, 2025

From SciSparc Ltd

Via GlobeNewswire

Get insights into the top gainers and losers of Friday's after-hours session. ↗

December 26, 2025

Via Chartmill

These stocks are moving in today's after hours session ↗

December 05, 2025

Via Chartmill

SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company

December 02, 2025

From SciSparc Ltd

Via GlobeNewswire

SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio

December 01, 2025

From SciSparc Ltd

Via GlobeNewswire

Traders are paying attention to the gapping stocks in Wednesday's session. ↗

November 26, 2025

Via Chartmill

Wednesday's pre-market session: top gainers and losers ↗

November 26, 2025

Via Chartmill

SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech ↗

November 26, 2025

Via Stocktwits

SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems

November 26, 2025

From SciSparc Ltd

Via GlobeNewswire

These stocks that are showing activity before the opening bell on Tuesday. ↗

November 25, 2025

Via Chartmill

SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

November 20, 2025

From SciSparc Ltd

Via GlobeNewswire

Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

November 17, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio

October 24, 2025

From SciSparc Ltd

Via GlobeNewswire

SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

October 23, 2025

From SciSparc Ltd

Via GlobeNewswire

SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery

October 23, 2025

From SciSparc Ltd

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 20, 2025

Via Benzinga

Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

October 20, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Frequently Asked Questions

Is SciSparc Ltd. - Ordinary Shares publicly traded?

Yes, SciSparc Ltd. - Ordinary Shares is publicly traded.

What exchange does SciSparc Ltd. - Ordinary Shares trade on?

SciSparc Ltd. - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for SciSparc Ltd. - Ordinary Shares?

The ticker symbol for SciSparc Ltd. - Ordinary Shares is SPRC on the Nasdaq Stock Market

What is the current price of SciSparc Ltd. - Ordinary Shares?

The current price of SciSparc Ltd. - Ordinary Shares is 5.650

When was SciSparc Ltd. - Ordinary Shares last traded?

The last trade of SciSparc Ltd. - Ordinary Shares was at 03/05/26 03:23 PM ET

What is the market capitalization of SciSparc Ltd. - Ordinary Shares?

The market capitalization of SciSparc Ltd. - Ordinary Shares is 820.09M

How many shares of SciSparc Ltd. - Ordinary Shares are outstanding?

SciSparc Ltd. - Ordinary Shares has 820M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.